ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Venlafaxin-Mepha Teva 37.5 mg, Tabletten - 30 Tablette(n)
60135001 Mepha Pharma AG
Venlafaxin-Mepha Teva 37.5 mg, Tabletten15.04.2010
  15.04.2010
Venlafaxine (N06AX16) 
WHO-DDD 
01.06.30 Tablette(n)
01.06. 
B  
No 
IP 
10.00  
k.A.19.65
7680601350013Synthetika
  
Composition
venlafaxinum 37.5 mg ut venlafaxini hydrochloridum, lactosum monohydricum 97.029 mg, silica colloidalis anhydrica, magnesii stearas, carboxymethylamylum natricum A corresp. natrium max. 0.315 mg, E 172 (flavum), E 172 (rubrum), pro compresso.
Packungsbestandteile
Tablets
 
Active AgentDose
Venlafaxine37.5 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Carboxymethylamylum Natricum A  
E 172 color.
Lactose Monohydrate97.029 mg 
Magnesii Stearas  
Pro Compresso  
Silica Colloidalis Anhydrica  
Source
Data was imported : 04.12.2014 Swissmedic Registration : 60135 Sequence : 01 Product name : Venlafaxin-Teva 37.5 mg, Tabletten Registration owner: : Teva Pharma AG Product group : Index Therapeuticus (BSV) : 01.06.0. Medication Code : Synthetika human Date of registration : 15.04.2010 Valid until : 14.04.2020 Package number : 001 Show package size : 30 Commercial Form/Unit : Tablette(n) Swissmedic categorie. : B Active Agents : venlafaxinum Composition : venlafaxinum 37.5 mg ut venlafaxini hydrochloridum, excipiens pro compresso.
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home